ArticleBMC public health2025
Hospital spending for cancers in Hunan, China during 2017 and 2019.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A nationwide survey on knowledge, attitude, and practice regarding human papillomavirus (HPV), HPV-related disease, and HPV vaccine among adolescents and their parents in China.Human vaccines & immunotherapeutics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectivesTo describe the hospitalization spending for cancers in Hunan Province, China, and to investigate the hospitalization cost across diverse cancer classifications.
methodsWe conducted a retrospective study based on the hospitalization admission data from 2017 to 2019 in Hunan Province. We retrieved information on age, sex, diagnosis, number of comorbidities, level of hospitalization, hospital location, hospital costs, length of stay, and type of payer for eligible participants. Factors for cost (log-transformed) were investigated through multiple linear regression.
resultsA total of 872,309 records of cancer were hospitalized in Hunan Province during 2017-2019, with a total cost of US$2490.36 million, and 64.10% of the cost was covered by medical insurance. The top five cancers in terms of cost were lung (300.32 million), colorectum ($234.56 million), liver ($126.46 million), lip, oral cavity & pharynx ($102.29 million), and stomach ($98.98 million) cancers in men, were breast ($176.03 million), colorectum ($156.15 million), cervix ($112.68 million), lung ($112.21 million), and thyroid ($56.75 million) cancers in women, respectively. Site of cancer, sex, age, year of hospitalization, number of comorbidities, length of stay, hospital level, and hospital location were significantly associated with the per-capita log-transformed cost.
conclusionThe economic burden of cancer was heavy in Hunan, and lung, colorectal, breast, liver, and stomach cancers accounted for half of the total cost. Site of cancer, sex, age, comorbidity, level, and location of hospital were factors for the per-capita cost.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.